Effects of Pristane on Cytochrome P450 Isozyme Expression in Rat Tissues

Carolyn B. Howard, Jacqueline Samuel, Shalonda B. Henderson, Jacqueline Stevens, Paul E. Thomas and Marvin A. Cuchens
Additional contact information
Carolyn B. Howard: Breast Cancer Research Laboratory, Department of Biology, and NIH-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P. O. Box 18540, Jackson, Mississippi, USA
Jacqueline Samuel: Breast Cancer Research Laboratory, Department of Biology, and NIH-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P. O. Box 18540, Jackson, Mississippi, USA
Shalonda B. Henderson: Breast Cancer Research Laboratory, Department of Biology, and NIH-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P. O. Box 18540, Jackson, Mississippi, USA
Jacqueline Stevens: Breast Cancer Research Laboratory, Department of Biology, and NIH-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P. O. Box 18540, Jackson, Mississippi, USA
Paul E. Thomas: Laboratory for Cancer Research, College of Pharmacy, Rutgers University, Piscataway, NJ 08855-0789, USA
Marvin A. Cuchens: Department of Microbiology, University of Mississippi Medical Center, Jackson, MS 39216-4505, USA

IJERPH, 2005, vol. 2, issue 1, 1-9

Abstract: Chemical carcinogenesis studies are powerful tools to obtain information on potential mechanisms of chemical factors for malignancies. In this study Western blot analyses, using monoclonal antibodies specific for three different cytochrome P450 (CYP) isozymes (CYP1A1, CYP1A2 and CYP2B), were employed to examine the effect(s) of 3-methylcholanthrene and/or pristane (2,6,10,14-tetramethylpentadecane) on the basal and inducible levels of expression of CYP proteins within Copenhagen rat tissues. Pristane exposure led to tissue specific differences in the CYP isozymes expressed and elicited increased CYP protein expression over 3-methylcholanthrene induced levels in microsomes isolated from liver, Peyer's Patches, and thymus. Within the context of the chemical carcinogenesis model employed in this study, these observations correlated with the induction of B-cell malignancies by low doses of 3-methylcholanthrene and of thymic lymphomas by a high 3-methylcholanthrene dose. The data suggest that pristane treatment affects CYP isozyme expression. This pristane-mediated effect clearly could be a contributing factor in the chemical carcinogenesis of the previously observed lymphoid malignancies, and a possible basis for the tumor enhancing effects of pristane.

Keywords: Pristane; Cytochrome P450 (CYP); monoclonal antibodies; 3-methylcholanthrene; phenobarbital; Western blots (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2005
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/2/1/138/pdf (application/pdf)
https://www.mdpi.com/1660-4601/2/1/138/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:2:y:2005:i:1:p:138-146:d:2723

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().